Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
Eur Urol
.
2018 Dec;74(6):842-843.
doi: 10.1016/j.eururo.2018.08.011.
Epub 2018 Aug 28.
Authors
Michael Staehler
1
,
Dena Battle
2
,
Axel Bex
3
,
Hans Hammers
4
,
Daniel George
5
Affiliations
1
University of Munich, Department of Urology, Multidisciplinary Center on Renal Tumors, Munich, Germany. Electronic address:
[email protected]
.
2
Kidney Cancer Research Alliance KCCure, VA, USA.
3
The Netherlands Cancer Institute, Division of Surgical Oncology, Urology, Amsterdam, The Netherlands.
4
UT Southwest, Medical Center, Dallas, TX, USA.
5
Duke Cancer Institute, Durham, NC, USA.
PMID:
30170873
DOI:
10.1016/j.eururo.2018.08.011
No abstract available
Publication types
Comment
MeSH terms
Carcinoma, Renal Cell / surgery*
Humans
Kidney Neoplasms / surgery
Nephrectomy
Sunitinib*
Substances
Sunitinib